Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call
MISSISSAUGA, ON, March 11, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and fiscal 2024 after the market close on Tuesday, March 18, 2025. The Company will also hold a conference call on Wednesday, March 19, 2025 at 8:30am ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: |
Wednesday, March 19, 2025 |
TIME: |
8:30 a.m. ET |
DIAL-IN NUMBER: |
416-945-7677 or 888-699-1199 |
REPLAY: |
289-819-1450 or 888-660-6345 Code: 49540# |
Expires: March 26, 2025 |
|
WEBCAST: |
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
For further information: Graham Farrell, Investor Relations - Cipher Pharmaceuticals, [email protected], 416-842-9003
Share this article